While the biochemical role of SIRT6 in breast cancer is still not completely established, this study came to conclusion that stabilizing SIRT6 may be a clinical strategy to overcome trastuzumab resistance in breast cancer patients, therefore increasing their survival prognostics [64]. The gene discussed is SIRT6; the disease is breast cancer.